In vivo electrophysiological assessment
β
Lynne E. Rueter; Claude De Montigny; Pierre Blier
π
Article
π
1998
π
John Wiley and Sons
π
English
β 251 KB
π 1 views
Flibanserin (BIMT 17) has been described as a 5-HT 1A agonist with preferential affinity for postsynaptic 5-HT 1A receptors and as a 5-HT 2A antagonist. Indeed, using the forskolin-stimulated cAMP accumulation technique, flibanserin but not the 5-HT 1A agonists buspirone and 8-OH-DPAT had agonistic